Pancreatic cancer took Andy Lyons’ grandmother, mother, aunt, uncle, and brother. Could he prevent it from becoming his story, too?

Host Alisyn Camerota sits down with Andy to discuss his more than 20 years of surveillance through a familial pancreatic cancer research study. That vigilance made a life-changing difference in 2021, when his pancreatic cancer was detected early enough for him to undergo Whipple surgery just two weeks after diagnosis, followed by chemotherapy.

Today, Andy encourages anyone with a family history of pancreatic cancer to talk with their doctor about genetic testing.

PancChat is a collaboration produced by Let’s Win Pancreatic Cancer and PanCAN.

Resources:
Let's Win Pancreatic Cancer
PanCAN
Let's Win Clinical Trial Finder
PanCAN Clinical Trial Finder
Let's Win Doctor Finder
PanCAN Patient Services
Andy Lyon's Survivor Story
Andy Lyon's Survivor Video

Click here to view the episode transcript.

In this episode of PancChat, host Alisyn Camerota is joined by pancreatic neuroendocrine tumor, or PNET, patient Katie DeCarlo. Katie shares her experience living with stage IV cancer and how she has come to approach her diagnosis as a chronic condition she continues to manage while living her life to the fullest.

Katie shares her journey from diagnosis through treatment, including surgery, chemotherapy, liver ablation, and participation in a clinical trial. She reflects on what it means to manage PNET as a chronic condition, the emotional challenges of living with an ongoing diagnosis, and the importance of finding a supportive community. She also shares her optimism about the rapid advancements in PNET treatment and what they could mean for patients.

PancChat is produced in collaboration with Let’s Win Pancreatic Cancer and PanCAN.

Resources:

Let's Win Pancreatic Cancer
PanCAN
Let's Win Clinical Trial Finder
PanCAN Clinical Trial Finder
Let's Win Doctor Finder
PanCAN Patient Services

Not all pancreatic cancers are the same. While most patients are diagnosed with pancreatic adenocarcinoma, approximately 10% have pancreatic neuroendocrine tumors (PNETs). What makes PNETs different, and what does that mean for diagnosis, treatment, and care?

On this episode of PancChat, host Alisyn Camerota joins Dr. Diane Reidy-Lagunes, chief of the Division of Medical Oncology and vice president for oncology services at Duke University Health System, to explore the biology, symptoms, treatment, and outlook of PNETs.

Dr. Reidy-Lagunes explains why some PNETs can be monitored while others need treatment, how tumor grade helps guide care, and how expanding treatment options are helping many patients live for years – even with advanced disease. They also discuss emerging research and why a second opinion from a team with neuroendocrine expertise can help patients navigate their options.

PancChat is sponsored by Revolution Medicines and produced in collaboration with Let’s Win Pancreatic Cancer and PanCAN.

Resources:
Let's Win Pancreatic Cancer
PanCAN
Let's Win Clinical Trial Finder
PanCAN Clinical Trial Finder
Let's Win Doctor Finder
PanCAN Patient Services